• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种能消除 p53 缺陷细胞的遗传传感器。

Development of a genetic sensor that eliminates p53 deficient cells.

机构信息

Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307, Dresden, Germany.

German Cancer Consortium (DKTK), OncoRay-National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

出版信息

Nat Commun. 2017 Nov 13;8(1):1463. doi: 10.1038/s41467-017-01688-w.

DOI:10.1038/s41467-017-01688-w
PMID:29133879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5684360/
Abstract

The TP53 gene fulfills a central role in protecting cells from genetic insult. Given this crucial role it might be surprising that p53 itself is not essential for cell survival. Indeed, TP53 is the single most mutated gene across different cancer types. Thus, both a theoretical and a question of significant practical applicability arise: can cells be programmed to make TP53 an essential gene? Here we present a genetic p53 sensor, in which the loss of p53 is coupled to the rise of HSV-TK expression. We show that the sensor can distinguish both p53 knockout and cells expressing a common TP53 cancer mutation from otherwise isogenic TP53 wild-type cells. Importantly, the system is sensitive enough to specifically target TP53 loss-of-function cells with the HSV-TK pro-drug Ganciclovir both in vitro and in vivo. Our work opens new ways to programming cell intrinsic transformation protection systems that rely on endogenous components.

摘要

TP53 基因在保护细胞免受遗传损伤方面起着核心作用。鉴于其关键作用,p53 本身对于细胞存活并非必需可能会让人感到惊讶。事实上,TP53 是不同癌症类型中突变最多的单一基因。因此,既存在理论上的问题,也存在重大实际应用的问题:能否对细胞进行编程使 TP53 成为必需基因?在这里,我们提出了一种遗传 p53 传感器,其中 p53 的缺失与 HSV-TK 表达的上升相关联。我们表明,该传感器能够区分 p53 敲除细胞和表达常见 TP53 癌症突变的细胞与其他同基因 TP53 野生型细胞。重要的是,该系统足够灵敏,能够使用 HSV-TK 前药更昔洛韦在体外和体内特异性靶向 TP53 失活功能细胞。我们的工作为依赖内源性成分的细胞内在转化保护系统的编程开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/2fde7498e12f/41467_2017_1688_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/c0fe8c4ccdb4/41467_2017_1688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/3d7e6d2ac131/41467_2017_1688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/36f51d83f9c7/41467_2017_1688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/c2553480b9a8/41467_2017_1688_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/bd736368a29b/41467_2017_1688_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/2fde7498e12f/41467_2017_1688_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/c0fe8c4ccdb4/41467_2017_1688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/3d7e6d2ac131/41467_2017_1688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/36f51d83f9c7/41467_2017_1688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/c2553480b9a8/41467_2017_1688_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/bd736368a29b/41467_2017_1688_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09e/5684360/2fde7498e12f/41467_2017_1688_Fig6_HTML.jpg

相似文献

1
Development of a genetic sensor that eliminates p53 deficient cells.开发一种能消除 p53 缺陷细胞的遗传传感器。
Nat Commun. 2017 Nov 13;8(1):1463. doi: 10.1038/s41467-017-01688-w.
2
Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.腺病毒介导的CD/5-氟胞嘧啶和单纯疱疹病毒1型胸苷激酶/更昔洛韦自杀基因疗法与p53基因疗法联合应用的疗效
Clin Cancer Res. 1999 Dec;5(12):4224-32.
3
Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.外源性p53和ASPP2表达增强了rAdV-TK/GCV对缺乏功能性p53的肝癌细胞的诱导死亡作用。
Oncotarget. 2016 Apr 5;7(14):18896-905. doi: 10.18632/oncotarget.7749.
4
Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.腺病毒介导单纯疱疹病毒胸苷激酶基因转移后乳腺癌细胞对更昔洛韦治疗的差异化学敏感性
Cancer Gene Ther. 1999 Mar-Apr;6(2):179-90. doi: 10.1038/sj.cgt.7700005.
5
P53-dependent cell-killing by selective repression of thymidine kinase and reduced prodrug activation.通过选择性抑制胸苷激酶和减少前药激活实现的p53依赖性细胞杀伤。
Mol Pharmacol. 2003 Aug;64(2):289-97. doi: 10.1124/mol.64.2.289.
6
Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.重组痘苗病毒-单纯疱疹病毒胸苷激酶/丙氧鸟苷自杀基因治疗系统对胃癌的实验研究
Cancer Biother Radiopharm. 2007 Dec;22(6):755-61. doi: 10.1089/cbr.2007.346.
7
Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis.更昔洛韦诱导表达疱疹病毒胸苷激酶的非增殖性甲状腺细胞消融是通过不依赖p53的凋亡实现的。
Oncogene. 1996 Jul 4;13(1):55-61.
8
Self-deleting suicide vectors (SDSV): selective killing of p53-deficient cancer cells.自我删除自杀载体(SDSV):选择性杀伤p53缺陷型癌细胞。
Cancer Res. 2001 Sep 15;61(18):6925-30.
9
Increased bax expression is associated with cell death induced by ganciclovir in a herpes thymidine kinase gene-expressing glioma cell line.在表达疱疹胸苷激酶基因的胶质瘤细胞系中,bax表达增加与更昔洛韦诱导的细胞死亡相关。
Hum Gene Ther. 1999 Mar 1;10(4):679-88. doi: 10.1089/10430349950018751.
10
The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells.Tet-On调控的单纯疱疹病毒胸苷激酶/丙氧鸟苷自杀基因系统在MCF-7细胞中引起的细胞死亡和DNA损伤。
Biomed Pharmacother. 2014 Sep;68(7):887-92. doi: 10.1016/j.biopha.2014.07.018. Epub 2014 Jul 28.

引用本文的文献

1
Single-cell analysis of matrisome-related genes in breast invasive carcinoma: new avenues for molecular subtyping and risk estimation.乳腺浸润性癌中基质相关基因的单细胞分析:分子亚型和风险评估的新途径。
Front Immunol. 2024 Oct 18;15:1466762. doi: 10.3389/fimmu.2024.1466762. eCollection 2024.
2
Cucurbitacin B Inhibits the Proliferation of WPMY-1 Cells and HPRF Cells via the p53/MDM2 Axis.葫芦素 B 通过 p53/MDM2 轴抑制 WPMY-1 细胞和 HPRF 细胞的增殖。
Int J Mol Sci. 2024 Aug 28;25(17):9333. doi: 10.3390/ijms25179333.
3
Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy.

本文引用的文献

1
Synthetic biology-inspired therapies for metabolic diseases.基于合成生物学的代谢疾病治疗方法。
Curr Opin Biotechnol. 2017 Oct;47:59-66. doi: 10.1016/j.copbio.2017.06.004. Epub 2017 Jun 26.
2
The Transcriptional Landscape of p53 Signalling Pathway.p53 信号通路的转录景观。
EBioMedicine. 2017 Jun;20:109-119. doi: 10.1016/j.ebiom.2017.05.017. Epub 2017 May 18.
3
Census and evaluation of p53 target genes.p53靶基因的普查与评估
合成生物学方法提高癌症免疫治疗的特异性和疗效。
Cell Mol Immunol. 2024 May;21(5):436-447. doi: 10.1038/s41423-024-01153-x. Epub 2024 Apr 11.
4
Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC - A systematic review.免疫调节框架及微小RNA在非小细胞肺癌发病机制中的作用——一项系统综述
Front Oncol. 2022 Dec 21;12:1089320. doi: 10.3389/fonc.2022.1089320. eCollection 2022.
5
Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors.通过同时获得/丧失转录因子的合成 CRISPRa 电路实现精确的肿瘤免疫重编程。
Nat Commun. 2022 Mar 18;13(1):1454. doi: 10.1038/s41467-022-29120-y.
6
Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment.纳米技术辅助的基于细菌的癌症治疗药物和基因递送系统的最新进展
Pharmaceutics. 2021 Jun 24;13(7):940. doi: 10.3390/pharmaceutics13070940.
7
Synthesis of RNA-based gene regulatory devices for redirecting cellular signaling events mediated by p53.基于 RNA 的基因调控器件的合成,用于重定向由 p53 介导的细胞信号事件。
Theranostics. 2021 Mar 4;11(10):4688-4698. doi: 10.7150/thno.55856. eCollection 2021.
8
A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin.一种通过激活p53和E-钙黏蛋白来抑制膀胱癌细胞进展的光诱导型分裂dCas9系统。
Front Mol Biosci. 2021 Jan 5;7:627848. doi: 10.3389/fmolb.2020.627848. eCollection 2020.
9
Engineering Cellular Signal Sensors based on CRISPR-sgRNA Reconstruction Approaches.基于 CRISPR-sgRNA 重构方法的工程细胞信号传感器。
Int J Biol Sci. 2020 Feb 21;16(8):1441-1449. doi: 10.7150/ijbs.42299. eCollection 2020.
10
Synthetic Biology Speeds Up Drug Target Discovery.合成生物学加速药物靶点发现。
Front Pharmacol. 2020 Feb 26;11:119. doi: 10.3389/fphar.2020.00119. eCollection 2020.
Oncogene. 2017 Jul 13;36(28):3943-3956. doi: 10.1038/onc.2016.502. Epub 2017 Mar 13.
4
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo.p53杂合性缺失是体内突变型p53稳定及功能获得的必要前提条件。
Cell Death Dis. 2017 Mar 9;8(3):e2661. doi: 10.1038/cddis.2017.80.
5
Exploiting the p53 Pathway for Therapy.利用p53信号通路进行治疗。
Cold Spring Harb Perspect Med. 2017 Mar 1;7(3):a026310. doi: 10.1101/cshperspect.a026310.
6
The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.p53蛋白对细胞功能的调控:细胞衰老
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026112. doi: 10.1101/cshperspect.a026112.
7
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.野生型和癌症相关突变型p53的转录调控
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026054. doi: 10.1101/cshperspect.a026054.
8
Targeting mutant p53 in cancer: a long road to precision therapy.靶向癌症中的突变型 p53:通往精准治疗的漫长道路。
FEBS J. 2017 Mar;284(6):837-850. doi: 10.1111/febs.13948. Epub 2016 Nov 20.
9
Directing cellular information flow via CRISPR signal conductors.通过 CRISPR 信号导体来定向细胞信息流。
Nat Methods. 2016 Nov;13(11):938-944. doi: 10.1038/nmeth.3994. Epub 2016 Sep 5.
10
Somatic TP53 Mutations in the Era of Genome Sequencing.基因组测序时代的体细胞TP53突变
Cold Spring Harb Perspect Med. 2016 Nov 1;6(11):a026179. doi: 10.1101/cshperspect.a026179.